LINC01475: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

Target Name: LINC01475

NCBI ID: G101927324

LINC01475

Other Name(s): long intergenic non-protein coding RNA 1475 | Long intergenic non-protein coding RNA 1475

LINC01475: A Long Intergenic Non-Protein Coding RNA as a Drug Target or Biomarker

LINC01475 is a long intergenic non-protein coding RNA (lncRNA) that has been identified in various studies as a potential drug target or biomarker. It is a non-coding RNA molecule that is expressed in various tissues and cells, including brain, heart, and liver. The function of LINC01475 is not well understood, but its potential involvement in various biological processes makes it an attractive target for research and development of new therapeutic strategies.

Drug Target Potential

LINC01475 has been shown to play a role in several cellular processes, including cell adhesion, migration, and survival. It has been shown to promote the formation of blood vessels in the brain and has been linked to the development of certain neurological disorders. Additionally, LINC01475 has been shown to play a role in cancer progression and has been associated with the development of certain types of cancer.

Biomarker Potential

The discovery of LINC01475 as a potential drug target or biomarker has significant implications for the development of new diagnostic and therapeutic strategies. If LINC01475 is proven to be a valid drug target, it could lead to the development of new treatments for various diseases, including neurological disorders, cancer, and diabetes. Additionally, if LINC01475 is found to be a valuable biomarker, it could be used to monitor the effectiveness of existing treatments and to identify new biomarkers for the diagnosis of certain diseases.

Methodology

To study the potential drug target or biomarker properties of LINC01475, researchers have used a variety of techniques, including RNA sequencing, qRT-PCR, and biochemical assays. These studies have shown that LINC01475 is involved in several cellular processes, including cell adhesion, migration, and survival.

Conclusion

LINC01475 is a long intergenic non-protein coding RNA that has been identified as a potential drug target or biomarker. Its potential involvement in various cellular processes makes it an attractive target for research and development of new therapeutic strategies. Further studies are needed to fully understand the function of LINC01475 and its potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1475

The "LINC01475 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01475 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets